Your browser doesn't support javascript.
loading
TDP-43 in nuclear condensates: where, how, and why.
Lang, Ruaridh; Hodgson, Rachel E; Shelkovnikova, Tatyana A.
Affiliation
  • Lang R; Sheffield Institute for Translational Neuroscience (SITraN) and Neuroscience Institute, University of Sheffield, Sheffield, U.K.
  • Hodgson RE; Sheffield Institute for Translational Neuroscience (SITraN) and Neuroscience Institute, University of Sheffield, Sheffield, U.K.
  • Shelkovnikova TA; Sheffield Institute for Translational Neuroscience (SITraN) and Neuroscience Institute, University of Sheffield, Sheffield, U.K.
Biochem Soc Trans ; 2024 Jul 03.
Article in En | MEDLINE | ID: mdl-38958608
ABSTRACT
TDP-43 is an abundant and ubiquitously expressed nuclear protein that becomes dysfunctional in a spectrum of neurodegenerative diseases. TDP-43's ability to phase separate and form/enter biomolecular condensates of varying size and composition is critical for its functionality. Despite the high density of phase-separated assemblies in the nucleus and the nuclear abundance of TDP-43, our understanding of the condensate-TDP-43 relationship in this cellular compartment is only emerging. Recent studies have also suggested that misregulation of nuclear TDP-43 condensation is an early event in the neurodegenerative disease amyotrophic lateral sclerosis. This review aims to draw attention to the nuclear facet of functional and aberrant TDP-43 condensation. We will summarise the current knowledge on how TDP-43 containing nuclear condensates form and function and how their homeostasis is affected in disease.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochem Soc Trans Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochem Soc Trans Year: 2024 Document type: Article Affiliation country: